{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:46:19Z","timestamp":1782524779847,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"R\u00e9gion Wallonne"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijantimicag.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T05:33:51Z","timestamp":1444800831000},"page":"660-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients"],"prefix":"10.1016","volume":"46","author":[{"given":"Stefaan J.","family":"Vandecasteele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Miranda Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Capron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0155","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1681\/ASN.2013101082","article-title":"A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination?","volume":"25","author":"Vandecasteele","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0160","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ndt\/16.6.1120","article-title":"Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries","volume":"16","author":"van Dijk","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0165","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2215\/CJN.04651107","article-title":"Multidrug-resistant Gram-negative bacteria among patients who require chronic hemodialysis","volume":"3","author":"Pop-Vicas","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0170","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ndt\/gfv205","article-title":"Gram-negative bacteraemia in haemodialysis","volume":"30","author":"Murray","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0175","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ndt\/gfv223","article-title":"Bacteraemia in haemodialysis patients\u2014not always Staphylococcus aureus","volume":"30","author":"Girndt","year":"2015","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ajhp\/60.2.178","article-title":"Cefazolin dosing protocol for patients receiving long-term hemodialysis","volume":"60","author":"Ahern","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1525-139X.2010.00803.x","article-title":"Vancomycin dosing in patients on intermittent hemodialysis","volume":"24","author":"Vandecasteele","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0190","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1128\/AAC.00474-13","article-title":"Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysis","volume":"57","author":"Loo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0200","unstructured":"Temocillin summary of product characteristics. http:\/\/www.medicines.org.uk [last updated 2012]."},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2015.09.005_bib0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003495-198500295-00023","article-title":"Effect of renal function and dialysis on temocillin pharmacokinetics","volume":"29","author":"Boelaert","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of \u03b2-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/11.4.349","article-title":"The pharmacokinetics of temocillin in patients with normal and impaired renal function","volume":"11","author":"Boelaert","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2013.12.002","article-title":"Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients","volume":"90","author":"Miranda Bastos","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0235","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinbiochem.2015.02.006","article-title":"Validation of a HPLC-MS\/MS assay for the determination of total and unbound concentration of temocillin in human serum","volume":"48","author":"Ngougni Pokem","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0240","series-title":"Applied clinical pharmacokinetics","first-page":"73","article-title":"Drug dosing in special populations: renal and hepatic disease, dialysis, heart failure, obesity, and drug interactions","author":"Bauer","year":"2008"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0245","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1755.2003.00819.x","article-title":"Gentamicin pharmacokinetics during slow daily home hemodialysis","volume":"63","author":"Manley","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0250","series-title":"Basic clinical pharmacokinetics","first-page":"111","article-title":"Dialysis of drugs","author":"Winter","year":"2004"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkm179","article-title":"Temocillin susceptibility by BSAC methodology","volume":"60","author":"Andrews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkq388","article-title":"Trends in production of extended-spectrum \u03b2-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals","volume":"66","author":"Rodriguez-Villalobos","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0265","series-title":"The pharmacokinetic basis for drug treatment","author":"Benet","year":"1984"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0270","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dku465","article-title":"Temocillin (6g daily) in critically ill patients: continuous infusion versus three times daily administration","volume":"70","author":"Laterre","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/12.1.47","article-title":"Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function","volume":"12","author":"Leroy","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0280","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2015.09.005_bib0285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003495-198500295-00028","article-title":"Temocillin pharmacokinetics in normal and impaired renal function","volume":"29","author":"Hoffler","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0290","series-title":"18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","article-title":"Temocillin protein binding is concentration-dependent and not restricted to albumin","author":"Carryn","year":"2008"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0295","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current (-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.09.005_bib0300","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1128\/AAC.49.12.4920-4927.2005","article-title":"Optimization of meropenem minimum concentration\/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa","volume":"49","author":"Tam","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T14:43:48Z","timestamp":1567262628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915003258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0924857915003258"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.09.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}